These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 19437321

  • 1. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles.
    Lukusa AK, Vermylen C, Vanabelle B, Curaba M, Brichard B, Chantrain C, Dupont S, Ferrant A, Wyns C.
    Pediatr Hematol Oncol; 2009 Jun; 26(4):186-94. PubMed ID: 19437321
    [Abstract] [Full Text] [Related]

  • 2. Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease.
    Grigg A.
    Intern Med J; 2007 Mar; 37(3):190-2. PubMed ID: 17316339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 5. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
    Elchuri SV, Williamson RS, Clark Brown R, Haight AE, Spencer JB, Buchanan I, Hassen-Schilling L, Brown MR, Mertens AC, Meacham LR.
    Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
    [Abstract] [Full Text] [Related]

  • 6. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A, de Bisotti R, Sumoza D, Fairbanks V.
    Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
    [Abstract] [Full Text] [Related]

  • 7. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease.
    Jain DL, Sarathi V, Desai S, Bhatnagar M, Lodha A.
    Hemoglobin; 2012 Nov; 36(4):323-32. PubMed ID: 22734586
    [Abstract] [Full Text] [Related]

  • 8. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males.
    Berthaut I, Guignedoux G, Kirsch-Noir F, de Larouziere V, Ravel C, Bachir D, Galactéros F, Ancel PY, Kunstmann JM, Levy L, Jouannet P, Girot R, Mandelbaum J.
    Haematologica; 2008 Jul; 93(7):988-93. PubMed ID: 18508803
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea treatment of sickle cell anemia in hospital-based practices.
    Ferguson RP, Arun A, Carter C, Walker SD, Castro O.
    Am J Hematol; 2002 Aug; 70(4):326-8. PubMed ID: 12214583
    [Abstract] [Full Text] [Related]

  • 10. [Effect of hydroxyurea on hemoglobin S].
    Torres AF, Eberle SE, Sciuccati G, Bonduel M.
    Medicina (B Aires); 2003 Aug; 63(2):140-2. PubMed ID: 12793083
    [Abstract] [Full Text] [Related]

  • 11. Use of hydroxyurea in children with sickle cell disease: what comes next?
    Ohene-Frempong K, Smith-Whitley K.
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199
    [Abstract] [Full Text] [Related]

  • 12. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.
    Lanzkron S, Haywood C, Segal JB, Dover GJ.
    Am J Hematol; 2006 Dec; 81(12):927-32. PubMed ID: 16924648
    [Abstract] [Full Text] [Related]

  • 13. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A, Ware RE, Thornburg CD.
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia].
    Elira Dokekias A, Okandze Elenga JP, Ndinga J, Sanogo I, Sangare A.
    Tunis Med; 2005 Jan; 83(1):32-7. PubMed ID: 15881719
    [Abstract] [Full Text] [Related]

  • 15. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
    Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE.
    J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
    [Abstract] [Full Text] [Related]

  • 16. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia.
    Silva DG, Belini Junior E, Torres Lde S, Ricci Júnior O, Lobo Cde C, Bonini-Domingos CR, de Almeida EA.
    Blood Cells Mol Dis; 2011 Jun 15; 47(1):23-8. PubMed ID: 21489839
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyurea in children: present and future.
    Vichinsky EP.
    Semin Hematol; 1997 Jul 15; 34(3 Suppl 3):22-9. PubMed ID: 9317198
    [Abstract] [Full Text] [Related]

  • 18. Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease.
    Joseph L, Jean C, Manceau S, Chalas C, Arnaud C, Kamdem A, Pondarré C, Habibi A, Bernaudin F, Allali S, de Montalembert M, Boutonnat-Faucher B, Arlet JB, Koehl B, Cavazzana M, Ribeil JA, Lionnet F, Berthaut I, Brousse V.
    Blood; 2021 Feb 11; 137(6):826-829. PubMed ID: 32976551
    [Abstract] [Full Text] [Related]

  • 19. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
    Tavakkoli F, Nahavandi M, Wyche MQ, Castro O.
    Clin Ther; 2005 Jul 11; 27(7):1083-8. PubMed ID: 16154487
    [Abstract] [Full Text] [Related]

  • 20. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea.
    Friedrisch JR, Prá D, Maluf SW, Bittar CM, Mergener M, Pollo T, Kayser M, da Silva MA, Henriques JA, da Rocha Silla LM.
    Mutat Res; 2008 Jan 08; 649(1-2):213-20. PubMed ID: 17988936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.